Obesity, Overweight, or Chronic Weight Management
2 clinical trials · Condition
◉ Watch Obesity, Overweight, or Chronic Weight Management
| Record | Firm | Date |
|---|---|---|
| Aleniglipron Phase 2 Body Composition Study (NCT07169942) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2025-08-15 |
| A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity (NCT06693843) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2024-10-28 |
Track Obesity, Overweight, or Chronic Weight Management automatically
Every clearance here is in the API, with alerts when new ones post.